1. Home
  2. SMID vs MSLE Comparison

SMID vs MSLE Comparison

Compare SMID & MSLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Smith-Midland Corporation

SMID

Smith-Midland Corporation

HOLD

Current Price

$35.11

Market Cap

151.1M

Sector

Industrials

ML Signal

HOLD

MSLE

Satellos Bioscience Inc. Common Stock

N/A

Current Price

$7.12

Market Cap

146.9M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
SMID
MSLE
Founded
1960
N/A
Country
United States
Canada
Employees
N/A
17
Industry
Building Materials
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
151.1M
146.9M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
SMID
MSLE
Price
$35.11
$7.12
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
6.1K
41.4K
Earning Date
04-14-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
62.76
N/A
EPS
2.36
N/A
Revenue
$93,446,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$14.92
N/A
Revenue Growth
19.03
N/A
52 Week Low
$25.60
$5.50
52 Week High
$43.62
$13.39

Technical Indicators

Market Signals
Indicator
SMID
MSLE
Relative Strength Index (RSI) 63.36 51.74
Support Level $35.80 $6.73
Resistance Level $36.89 $9.50
Average True Range (ATR) 1.32 0.64
MACD 0.26 0.07
Stochastic Oscillator 100.00 56.27

Price Performance

Historical Comparison
SMID
MSLE

About SMID Smith-Midland Corporation

Smith-Midland Corp through its subsidiaries invents, develops, manufactures, markets, sells, and installs precast concrete products for primary use in the construction, highway, utilities, and farming industries. The firm's customers are general contractors and federal, state, and local transportation authorities. Its products include Slenderwall, JJhooks, Softsound, Sierra Wall and Easi set. A substantial portion of the company's business is derived from local, state, and federal building projects. The company generates revenues predominantly from the sale, leasing, licensing, shipping, and installation of precast concrete products for the construction, utility, and farming industries.

About MSLE Satellos Bioscience Inc. Common Stock

Satellos Bioscience Inc is a regenerative medicine company a biotechnology and drug development company. The company is developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. The company's program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation which Satellos has identified as a root cause of the progressive nature of this disease.

Share on Social Networks: